Efficacy of Chemotherapy After Progression During or Following PARP Inhibitor Exposure in Patients With Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer
ESMO Open 2024 Sep 03;9(9)103694, A Xu-Vuillard, C Guerin-Charbonnel, F Bocquet, S Cheeseman, PM Kubelac, M Zenatri, G Hall, P Achimas-Cadariu, B Hanvic, H Fenton, AM Sturz-Lazăr, P Augereau, IR Coquard, A Leary, JS FrenelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.